Skip to content
Company Analysis

Bausch Health Companies Inc. BHC

A comprehensive view of key metrics, scores, and financial health for Bausch Health Companies Inc.

Overview of Bausch Health Companies Inc.

BHC NYQ
Healthcare Drug Manufacturers - Specialty & Generic Framework: Pharma / Mature Biotech Small Cap
Bausch Health Companies Inc. (BHC), is a Small Cap company, in the Drug Manufacturers - Specialty & Generic industry, last closed at $5.06, about 1097.2% undervalued vs fair value, -14.4% 1Y return, ranked 371/1122 in sector.
Metrics Rev Growth 7.1% ROE -17.0% Gross Margin 68.3%
USD 5.06
-1.94%
(Delayed)
• Vol 90d: 39.8%
52-Week Range
Market Cap
$1.93B
Enterprise Value
$21.81B
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Fair
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Fair
Completeness: 82%
Confidence: 79%
Updated: Mar 8
Top Beats

Quick Facts

Website https://www.bauschhealth.com
HQ Laval, QC
Employees 20,300
Fiscal year Dec 31

Next Events

Earnings Jul 29 Estimated

Fair Value Snapshot

Bear Base Bull
$55
$61
$66
Current: $5.06 +1097% vs base

Engine Room Money Flow™

Small Cap

Pharmaceutical / Mature Biotech - Where revenue goes and how value is created

Flow Steps
Total Revenue
$10.3B
7.1%%
Gross Profit
$7.0B
2.9%%
R&D Expense
$739.0M
20%%
Operating Income (EBIT)
$1.9B
21.1%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Pharmaceutical / Mature Biotech

Quality & Reliability Indicators

Cash Conversion
74.4%
Fair

Moderate cash conversion - some working capital drag

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
4
Active Leaks
3/4
Improving
1
High Impact
1
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Bausch Health Companies Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
62
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Strong
79
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 95% Coverage
Trade-Off Triangle Visualization A ternary plot showing BHC's balance between Growth (32.7%), Profitability (37.6%), and Safety (29.6%). Growth 33% Safety 30% Profitability 38%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

56th percentile vs peers
57
Key Signals
EPS Growth YoY 92.0% 83p Rev Growth YoY 7.1% 53p Revenue CAGR 3Y 8.3% 57p TSR -78.1% 14p
Strengths
  • EPS Growth YoY in top 20% of peers (92.0%, 83th percentile)
  • Superior capital returns - 2 return metrics above peer median
  • Net Debt/EBITDA in top 20% of peers (7.24, 87th percentile)
  • Debt/FCF Ratio in top 20% of peers (17.20, 95th percentile)
Risks

No significant risks identified for this axis.

Profitability

65th percentile vs peers
66
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

51th percentile vs peers
52
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Bausch Health Companies Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$60.58
- - -
+1097.2% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000